AP
ACCPL

Accretion Pha.

Pharmaceuticals
Share price
₹207
Market cap
₹141 Cr
1Y return
▲ 155%

A pharmaceutical manufacturer incorporated in 2012, Accretion Pharmaceuticals produces tablets, capsules, and other healthcare products for domestic and international markets. The company operates across multiple therapeutic segments, focusing on formulation development, quality manufacturing, and distribution. Its distinctive strength lies in vertically integrated operations combining research capabilities with modern production facilities and a wide distribution network across India and select overseas regions.

Investors holding Accretion Pha.

3.65%

Recent moves 3

Unicorn FundIncreased
Unicorn Fund increased its stake in Accretion Pha. from 2.76% to 3.65% by acquiring 98,400 shares, taking its total holding to 4,05,600 shares.
17 Oct 2026
Read more
Unicorn FundNew position
Unicorn Fund acquired 3,07,200 shares, representing a 2.76% stake in Accretion Pharmaceuticals.
16 Jul 2026
Read more
Unicorn FundNew position
Unicorn Fund bought 67,200 shares of Accretion Pharmaceuticals for ₹69 lakh at ₹102.60 apiece in a bulk deal on April 29, 2026.
29 Apr 2026
Read more

Track the whales in Accretion Pha.

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1